U.S. stocks moved lower as a selloff in health care soured the jobs-inspired rally that pushed benchmark indices to record highs last week. A jump in crude prices helped to keep losses shallow. Bristol-Myers Squibb (BMY) led the health care sector lower after Credit Suisse cut its rating to NEUTRAL from OUTPERFORM. The biotech company slumped on Friday in the second-biggest one-day drop in its history after disappointing trial results for a highly-anticipated lung cancer treatment. 21st Century Fox (FOXA) was downgraded to EQUAL WEIGHT from OVERWEIGHT at Barclays. The firm also removed the stock from its top picks list, citing a lack of near-term catalysts. Dean Foods (DF) slipped after recording another quarter of declining sales, its sixth quarter in a row. However, lower raw milk costs did help to drive profit higher.
More from Video
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.
AMSC CEO discusses that and China challenges.
One of pharma's biggest CEO's talks M&A action on the exchange.